Fennec Pharmaceuticals, Inc. (FENC)
12.76
+1.14
(+9.81%)
USD |
NASDAQ |
Nov 16, 16:00
12.58
-0.18
(-1.41%)
After-Hours: 20:00
Fennec Pharmaceuticals Shareholders Equity (Quarterly) : 49.19M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 49.19M |
| June 30, 2026 | 42.44M |
| March 31, 2026 | 37.68M |
| December 31, 2025 | 35.47M |
| September 30, 2025 | -4.492M |
| June 30, 2025 | -7.463M |
| March 31, 2025 | -5.88M |
| December 31, 2024 | -5.872M |
| September 30, 2024 | -5.171M |
| June 30, 2024 | -1.357M |
| March 31, 2024 | 3.014M |
| December 31, 2023 | -11.62M |
| September 30, 2023 | -10.53M |
| June 30, 2023 | -9.727M |
| March 31, 2023 | -7.339M |
| December 31, 2022 | -2.569M |
| September 30, 2022 | 2.802M |
| June 30, 2022 | 8.541M |
| March 31, 2022 | 12.52M |
| December 31, 2021 | 15.77M |
| September 30, 2021 | 19.01M |
| June 30, 2021 | 22.28M |
| March 31, 2021 | 24.93M |
| December 31, 2020 | 29.07M |
| September 30, 2020 | 31.18M |
| Date | Value |
|---|---|
| June 30, 2020 | 36.13M |
| March 31, 2020 | 8.461M |
| December 31, 2019 | 11.88M |
| September 30, 2019 | 15.00M |
| June 30, 2019 | 16.48M |
| March 31, 2019 | 19.21M |
| December 31, 2018 | 21.31M |
| September 30, 2018 | 22.86M |
| June 30, 2018 | 24.86M |
| March 31, 2018 | 25.66M |
| December 31, 2017 | 26.76M |
| September 30, 2017 | 8.858M |
| June 30, 2017 | 9.679M |
| March 31, 2017 | 2.861M |
| December 31, 2016 | 3.57M |
| September 30, 2016 | 4.22M |
| June 30, 2016 | 4.653M |
| March 31, 2016 | 0.243M |
| December 31, 2015 | 0.548M |
| September 30, 2015 | 1.019M |
| June 30, 2015 | 1.112M |
| March 31, 2015 | 0.826M |
| December 31, 2014 | 0.613M |
| September 30, 2014 | -3.228M |
| June 30, 2014 | -4.658M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.387B |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
| Anika Therapeutics, Inc. | 137.58M |
| Savara, Inc. | 107.85M |
| Arrowhead Pharmaceuticals, Inc. | 50.31M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 83.54M |
| Total Liabilities (Quarterly) | 34.35M |
| Current Ratio | 6.112 |
| Net Debt Paydown Yield | 0.96% |